Azithromycin for mild-to-moderate COVID-19 - Authors' reply

Azithromycin for mild-to-moderate COVID-19 - Authors' reply

Show other versions (1)

Bibliographic Details
Main Author:	Hinks, TSC
Other Authors:	ATOMIC2 Trial Authors
Format:	Journal article
Language:	English
Published:	Elseiver 2021